Renal replacement therapy in XXXX with @entity2316 , 1980-1985. Report from the European Dialysis and Transplant Association Registry.

@entity1 @entity296 @entity66 @entity6 @entity2316 @entity5 @entity1188 @entity204 @entity454
@entity2316 , a rarely listed cause of @entity454 ( @entity454 ) among @entity1 starting renal replacement therapy (RRT) in the early seventies, has progressively gained in importance and become one of the major reasons for the continuous growth of the @entity1 population on RRT in most European countries. Amongst new @entity1 commencing RRT in 1985, the acceptance rate varied between 3 and 12 per million population for @entity6 and between one and four per million population for @entity6 . Nordic countries, particularly Sweden and Finland, had the highest acceptance rate of young @entity1 with @entity6 whose median ages were 38-42 years. In most central and southern European countries the median age of @entity1 with @entity6 varied between 50 and 58 years. The high number of young @entity1 with @entity6 and @entity454 in Nordic countries point to a different natural history of this disease. It cannot be excluded, however, that the higher median age in other countries might result from doctors mistakenly diagnosing type I disease in @entity1 with @entity66 who need insulin treatment. @entity1 with @entity6 had a similar age distribution at start of RRT throughout Europe and their median ages clustered around 60 years in most countries. The contribution of haemodialysis, peritoneal dialysis and renal transplantation was analysed for @entity6 compared to non- @entity6 @entity454 . Despite large geographical differences in the proportional use of methods of treatment, a general trend to apply CAPD more frequently in @entity6 as compared to non- @entity6 @entity1 was observed, and this was true for countries with both predominant haemodialysis and predominant transplant programmes. Transplantation without prior dialysis was performed in 17% of Swedish and 30% of Norwegian @entity1 with @entity6 . In order to better explain the mortality of @entity1 with @entity6 @entity454 , the proportional distribution of causes of @entity204 was analysed. @entity296 and @entity1188 was confirmed to be the leading cause of @entity204 in @entity1 with @entity6 on RRT. The coronary @entity204 rate was estimated to be 10 times greater in young @entity1 with @entity6 as compared to their non- @entity6 counterparts. Other cardiovascular as well as infectious causes were recorded in a similar proportion of @entity204 in diabetics as in non-diabetics. @entity5 @entity204 , however, appeared to be definitely less frequent in @entity1 on RRT due to @entity2316 .
